Characteristics of COVID-19 Infection in Beijing
Overview
Authors
Affiliations
Background: Since the first case of a novel coronavirus (COVID-19) infection pneumonia was detected in Wuhan, China, a series of confirmed cases of the COVID-19 were found in Beijing. We analyzed the data of 262 confirmed cases to determine the clinical and epidemiological characteristics of COVID-19 in Beijing.
Methods: We collected patients who were transferred by Beijing Emergency Medical Service to the designated hospitals. The information on demographic, epidemiological, clinical, laboratory test for the COVID-19 virus, diagnostic classification, cluster case and outcome were obtained. Furthermore we compared the characteristics between severe and common confirmed cases which including mild cases, no-pneumonia cases and asymptomatic cases, and we also compared the features between COVID-19 and 2003 SARS.
Findings: By Feb 10, 2020, 262 patients were transferred from the hospitals across Beijing to the designated hospitals for special treatment of the COVID-19 infected by Beijing emergency medical service. Among of 262 patients, 46 (17.6%) were severe cases, 216 (82.4%) were common cases, which including 192 (73.3%) mild cases, 11(4.2%) non-pneumonia cases and 13 (5.0%) asymptomatic cases respectively. The median age of patients was 47.5 years old and 48.5% were male. 192 (73.3%) patients were residents of Beijing, 50 (26.0%) of which had been to Wuhan, 116 (60.4%) had close contact with confirmed cases, 21 (10.9%) had no contact history. The most common symptoms at the onset of illness were fever (82.1%), cough (45.8%), fatigue (26.3%), dyspnea (6.9%) and headache (6.5%). The median incubation period was 6.7 days, the interval time from between illness onset and seeing a doctor was 4.5 days. As of Feb 10, 17.2% patients have discharged and 81.7% patients remain in hospital in our study, the fatality of COVID-19 infection in Beijing was 0.9%.
Interpretation: On the basis of this study, we provided the ratio of the COVID-19 infection on the severe cases to the mild, asymptomatic and non-pneumonia cases in Beijing. Population was generally susceptible, and with a relatively low fatality rate. The measures to prevent transmission was very successful at early stage, the next steps on the COVID-19 infection should be focused on early isolation of patients and quarantine for close contacts in families and communities in Beijing.
Funding: Beijing Municipal Science and Technology Commission and Ministry of Science and Technology.
Liu Q, Miao H, Shi C, Hu P, An S Medicine (Baltimore). 2024; 103(48):e40734.
PMID: 39612427 PMC: 11608705. DOI: 10.1097/MD.0000000000040734.
Survival of hospitalised COVID-19 patients in Hawassa, Ethiopia: a cohort study.
Anteneh A, LeBlanc M, Natnael A, Asfaw Z BMC Infect Dis. 2024; 24(1):1055.
PMID: 39333929 PMC: 11429985. DOI: 10.1186/s12879-024-09905-w.
Sadaya M, Anuran G Acta Med Philipp. 2024; 58(13):81-86.
PMID: 39166222 PMC: 11330990. DOI: 10.47895/amp.v58i13.8161.
Li Y, Xin Y, Li X, Zhang Y, Liu C, Cao Z Vis Comput Ind Biomed Art. 2024; 7(1):17.
PMID: 38976189 PMC: 11231110. DOI: 10.1186/s42492-024-00168-5.
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic.
Carvajal J, Garcia-Castillo V, Cuellar S, Campillay-Veliz C, Salazar-Ardiles C, Avellaneda A Front Immunol. 2024; 15:1363572.
PMID: 38911850 PMC: 11190347. DOI: 10.3389/fimmu.2024.1363572.